Head of Medical and Pharmacovigilance Department,
At the end of Medical School, after one year of Pharmaceutical Medicine program and a DES in management, S. Marreaud began her career as medical fellow at EORTC and had the opportunity to be exposed to full range of trainings, all of which tended to reinforce and solidify her intense interest in clinical research. After her fellowship, she was appointed as project leader for early phase trials and developed her expertise in the management of phase I trials and methodology for safety evaluation. Since her main interest remained scientific, she did pursue experience in clinical trials by taking over the position of clinical research physician in several EORTC disease oriented groups such as Breast, Chronotherapy, Gastro-Intestinal, Genito-Urinary, Soft Tissue and Bone Sarcoma (STBSG) and Melanoma groups. Her cooperation with the STBSG gave her opportunities to extend her knowledge and experience in rare disease field and in management of international trials. Since 2011, she has been appointed as Head of Medical and Pharmacovigilance Department and more recently also involved in the coordination of the EORTC Brain Metastases Research Platform.